410 Medical Raises $12 Million to Expand LifeFlow Infusion Technology

July 14, 2026
410 Medical has raised $12 million in financing led by Orlando Health Ventures, with funds aimed at expanding commercial operations and launching the next version of its LifeFlow infuser in 2027.

410 Medical has completed a $12 million financing round led by Orlando Health Ventures, announced in a press release. Participants in the round include Hatteras Venture Partners, Ballad Health, OSF Healthcare, Rex Health Ventures, CU Healthcare Innovations Fund, Sarnova, Catalyst by Wellstar, Tampa General, and a new undisclosed strategic investor.

The funding will support 410 Medical's commercial operations and the launch of the next version of its LifeFlow infuser, expected in 2027. The company plans to expand its presence among hospital systems and emergency medical service agencies in the United States.

410 Medical’s LifeFlow system is used in more than 500 hospitals and EMS agencies for rapid delivery of fluids and blood to patients experiencing sepsis, hemorrhagic shock, or other critical conditions. The company reports that approximately 80,000 patients have been treated with LifeFlow devices to date.

Founded in 2013 and based in Durham, North Carolina, 410 Medical focuses on technologies that improve fluid resuscitation for critically ill patients. Its first LifeFlow system received FDA clearance in 2016.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly, AI Funding Brief or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Funding News AI Brief AI Brief (X)

More from: Life Sciences

07/14
Mission North Expands Health Practice and Names Alex Hunter EVP of Health and Innovation
07/14
Newronika Receives CE Mark for Adaptive Deep Brain Stimulation System
07/14
ORTEC Acquires TOBA HR Solutions to Expand Healthcare Workforce Management in Belgium and Luxembourg
07/14
RWS Launches Integrated Linguistic Validation Service for Faster Clinical Trials
07/14
Filevine Partners With Codes Health for AI Medical Record Retrieval

More from: Funding

07/14
Sabanto Raises Series B Funding to Expand Autonomous Farming Technology
07/14
CleanSpark Signs 20-Year, $6.6 Billion Lease for Georgia Data Center
07/14
ORTEC Acquires TOBA HR Solutions to Expand Healthcare Workforce Management in Belgium and Luxembourg
07/14
Helsing Raises $1.8 Billion in Record European Defense Funding Round
07/14
Anshar Labs Acquires Dealer World, Appoints Dan Moore as Drivvr AI CEO

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like